The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_5829	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human ovarian carcinoma cell line	ES-2	80% confluency	NA	NA	13 pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5830	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human ovarian carcinoma cell line	SKOV3	80% confluency	NA	NA	24 pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5831	Newcastle disease virus	NDV-PPMK107	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human ovarian carcinoma cell line	OVCAR3	80% confluency	NA	NA	34 pfu	50% cancer cell death	No	No	NA	No response	NA	NA	NA	NA	US8105578
OV_5892	Adenovirus	CGTG-602	DNA	Adenoviridae	Virus E1A promoter is replaced by human E2F1 promoter	Yes	No	No	ATCC	Human ovarian carcinoma cell line	SKOV3	NA	NA	MTT assay	1 ×10⁴ pfu	80% of cancer cell death occurs after 100 days	No	No	NA	No response	NA	NA	NA	NA	US9410129